Morphic Holding, Inc. (MORF): Price and Financial Metrics

Morphic Holding, Inc. (MORF): $61.40

-2.58 (-4.03%)

POWR Rating

Component Grades













Add MORF to Watchlist
Sign Up

Industry: Biotech


of 505

in industry


  • MORF scores best on the Sentiment dimension, with a Sentiment rank ahead of 76.44% of US stocks.
  • The strongest trend for MORF is in Stability, which has been heading down over the past 48 weeks.
  • MORF's current lowest rank is in the Momentum metric (where it is better than 5.12% of US stocks).

MORF Stock Summary

  • MORF's went public 2.25 years ago, making it older than merely 4.5% of listed US stocks we're tracking.
  • The ratio of debt to operating expenses for Morphic Holding Inc is higher than it is for about just 0.49% of US stocks.
  • With a price/sales ratio of 60.78, Morphic Holding Inc has a higher such ratio than 95.68% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Morphic Holding Inc are RAPT, ATRA, DRNA, RNA, and NKTR.
  • MORF's SEC filings can be seen here. And to visit Morphic Holding Inc's official web site, go to

MORF Valuation Summary

  • In comparison to the median Healthcare stock, MORF's price/sales ratio is 421.59% higher, now standing at 59.2.
  • MORF's price/sales ratio has moved up 4.6 over the prior 27 months.
  • MORF's price/earnings ratio has moved down 15.7 over the prior 27 months.

Below are key valuation metrics over time for MORF.

Stock Date P/S P/B P/E EV/EBIT
MORF 2021-08-31 59.2 6.6 -37.3 -30.7
MORF 2021-08-30 58.1 6.5 -36.6 -30.0
MORF 2021-08-27 58.7 6.5 -37.0 -30.4
MORF 2021-08-26 58.2 6.5 -36.7 -30.1
MORF 2021-08-25 58.4 6.5 -36.8 -30.2
MORF 2021-08-24 57.1 6.4 -36.0 -29.4

MORF's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MORF has a Quality Grade of C, ranking ahead of 30.15% of graded US stocks.
  • MORF's asset turnover comes in at 0.114 -- ranking 252nd of 677 Pharmaceutical Products stocks.
  • 500 - Internal server error

The table below shows MORF's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.114 1 -1.111
2021-03-31 0.150 1 -0.797
2020-12-31 0.199 1 -0.595
2020-09-30 0.170 1 -0.597
2020-06-30 0.079 1 -0.807
2020-03-31 0.072 1 -0.604

MORF Price Target

For more insight on analysts targets of MORF, see our MORF price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $100.50 Average Broker Recommendation 1.4 (Strong Buy)

MORF Stock Price Chart Interactive Chart >

Price chart for MORF

MORF Price/Volume Stats

Current price $61.40 52-week high $93.00
Prev. close $63.98 52-week low $24.94
Day low $61.39 Volume 111,500
Day high $64.35 Avg. volume 271,559
50-day MA $61.04 Dividend yield N/A
200-day MA $52.44 Market Cap 2.24B

Morphic Holding, Inc. (MORF) Company Bio

Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.

MORF Latest News Stream

Event/Time News Detail
Loading, please wait...

MORF Latest Social Stream

Loading social stream, please wait...

View Full MORF Social Stream

Latest MORF News From Around the Web

Below are the latest news stories about Morphic Holding Inc that investors may wish to consider to help them evaluate MORF as an investment opportunity.

Insider Of Morphic Holding Trades $861.86 Thousand In Company Stock

Robert Farrell Jr., insider at Morphic Holding (NASDAQ:MORF), made a large buy and sell of company shares on September 13, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Robert Farrell Jr. purchased 4,974 Morphic Holding shares at a price of $4.32 per share for a total of $21,488 on September 13. They then sold their shares on multiple transactions in the open market. They sold at prices ranging from $65.01 to $65.14 to

Yahoo | September 15, 2021

Morphic Therapeutic Announces Participation in September Investor Conferences

WALTHAM, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced participation in the following investor conferences: Dr. Praveen Tipirneni, M.D., President and CEO, and Marc Schegerin, M.D., COO and CFO, are scheduled to take part in a fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference at 12:30 p.m. ET on Fr

Yahoo | September 1, 2021

Insider Buying: The Morphic Holding, Inc. (NASDAQ:MORF) Founder Just Bought 1.4% More Shares

Those following along with Morphic Holding, Inc. ( NASDAQ:MORF ) will no doubt be intrigued by the recent purchase of...

Yahoo | August 24, 2021

Morphic Therapeutic Announces Appointment of Nisha Nanda, Ph.D., to Board of Directors

WALTHAM, Mass., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced the appointment of Nisha Nanda, Ph.D., to its Board of Directors. Dr. Nanda currently serves as the chief development officer for Loxo Oncology at Lilly. “Nisha’s expertise overseeing preclinical and clinical-stage development strategy will be an asset to Morphic as w

Yahoo | August 23, 2021

Morphic Holding Inc (MORF): Price Now Near $56; Daily Chart Shows Downtrend on 50 Day Basis

This is a reversal of the price action on the previous hour, in which price moved up. The post Morphic Holding Inc (MORF): Price Now Near $56; Daily Chart Shows Downtrend on 50 Day Basis appeared first on ETF Daily News .

ETF Daily News | August 19, 2021

Read More 'MORF' Stories Here

MORF Price Returns

1-mo -1.76%
3-mo 6.99%
6-mo -5.51%
1-year 128.25%
3-year N/A
5-year N/A
YTD 83.01%
2020 95.51%
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 3.1796 seconds.